AMARIN CORP PLC\UK Operating Cash Flow
AMARIN CORP PLC\UK (AMRN) reported Operating Cash Flow of $12.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-29
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $6.60M, a 60.23% decline year-over-year.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $6.39M.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $15.28M.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$12.70M.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for fiscal 2025 was $6.73M.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for fiscal 2024 was -$31.02M, a 550.87% decline from fiscal 2023.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for fiscal 2023 was $6.88M.
- AMARIN CORP PLC\UK net cash provided by (used in) operating activities for fiscal 2022 was -$180.09M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $12.99M 10-Q · filed 2026-07-29 | $28.27M derived: sum of 3 quarters · filed 2026-07-29 | $15.57M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $6.39M 10-Q · filed 2026-04-29 | $21.67M derived: sum of 2 quarters · filed 2026-04-29 | $8.97M derived: sum of 3 quarters · filed 2026-04-29 | $25.57M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.58M derived: sum of 2 quarters · filed 2026-03-02 | $19.19M derived: sum of 3 quarters · filed 2026-07-29 | $6.73M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.91M derived: sum of 2 quarters · filed 2026-07-29 | -$8.55M 10-Q · filed 2025-10-29 | -$21.86M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $16.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $4.15M 10-Q · filed 2026-07-29 | -$9.16M derived: sum of 3 quarters · filed 2026-07-29 | -$11.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$12.46M 10-Q · filed 2026-04-29 | -$25.77M derived: sum of 2 quarters · filed 2026-04-29 | -$28.13M derived: sum of 3 quarters · filed 2026-04-29 | -$30.88M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$15.67M derived: sum of 2 quarters · filed 2026-03-02 | -$18.42M derived: sum of 3 quarters · filed 2026-03-02 | -$31.02M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$5.11M derived: sum of 2 quarters · filed 2025-10-29 | -$17.71M 10-Q · filed 2025-10-29 | -$18.36M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$15.35M 10-Q · filed 2025-07-30 | -$15.99M derived: sum of 3 quarters · filed 2026-03-02 | -$8.67M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$12.60M 10-Q · filed 2025-05-07 | -$13.25M derived: sum of 2 quarters · filed 2026-03-02 | -$5.92M derived: sum of 3 quarters · filed 2026-03-02 | $1.29M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $6.68M derived: sum of 2 quarters · filed 2026-03-02 | $13.89M derived: sum of 3 quarters · filed 2026-03-02 | $6.88M 10-K · filed 2026-03-02 |
| 2023-09-30 | $7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $14.53M derived: sum of 2 quarters · filed 2024-10-30 | $7.53M 10-Q · filed 2024-10-30 | $9.08M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $196.00K 10-Q · filed 2024-07-31 | $1.75M derived: sum of 3 quarters · filed 2025-03-12 | -$16.46M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | -$7.01M 10-Q · filed 2024-05-01 | -$5.46M derived: sum of 2 quarters · filed 2025-03-12 | -$23.67M derived: sum of 3 quarters · filed 2025-03-12 | -$88.25M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$16.66M derived: sum of 2 quarters · filed 2025-03-12 | -$81.25M derived: sum of 3 quarters · filed 2025-03-12 | -$180.09M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$18.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$82.80M derived: sum of 2 quarters · filed 2023-11-01 | -$181.64M 10-Q · filed 2023-11-01 | -$209.88M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$64.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$163.43M 10-Q · filed 2023-08-02 | -$191.67M derived: sum of 3 quarters · filed 2024-02-29 | -$196.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$98.85M 10-Q · filed 2023-05-03 | -$127.09M derived: sum of 2 quarters · filed 2024-02-29 | -$131.63M derived: sum of 3 quarters · filed 2024-02-29 | -$146.68M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$28.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$32.78M derived: sum of 2 quarters · filed 2024-02-29 | -$47.83M derived: sum of 3 quarters · filed 2024-02-29 | -$66.54M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$19.59M derived: sum of 2 quarters · filed 2022-10-27 | -$38.30M 10-Q · filed 2022-10-27 | -$76.62M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$15.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$33.76M 10-Q · filed 2022-08-03 | -$72.08M derived: sum of 3 quarters · filed 2023-03-01 | -$61.23M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$18.70M 10-Q · filed 2022-05-04 | -$57.03M derived: sum of 2 quarters · filed 2023-03-01 | -$46.17M derived: sum of 3 quarters · filed 2023-03-01 | -$44.59M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$38.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$27.47M derived: sum of 2 quarters · filed 2023-03-01 | -$25.88M derived: sum of 3 quarters · filed 2023-03-01 | -$21.75M 10-K · filed 2023-03-01 |
| 2020-09-30 | $10.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $12.44M derived: sum of 2 quarters · filed 2021-11-03 | $16.58M 10-Q · filed 2021-11-03 | $7.64M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $5.72M 10-Q · filed 2021-08-05 | -$3.21M derived: sum of 3 quarters · filed 2022-03-01 | $18.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $4.14M 10-Q · filed 2021-04-29 | -$4.80M derived: sum of 2 quarters · filed 2022-03-01 | $16.95M derived: sum of 3 quarters · filed 2022-03-01 | $32.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $12.81M derived: sum of 2 quarters · filed 2022-03-01 | $28.72M derived: sum of 3 quarters · filed 2022-03-01 | -$9.37M 10-K · filed 2022-03-01 |
| 2019-09-30 | $21.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $37.66M derived: sum of 2 quarters · filed 2020-11-05 | -$430.00K 10-Q · filed 2020-11-05 | -$32.73M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $15.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$22.18M 10-Q · filed 2020-08-04 | -$54.48M derived: sum of 3 quarters · filed 2021-02-25 | -$82.64M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$38.09M 10-Q · filed 2020-04-30 | -$70.39M derived: sum of 2 quarters · filed 2021-02-25 | -$98.55M derived: sum of 3 quarters · filed 2021-02-25 | -$122.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$32.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$60.46M derived: sum of 2 quarters · filed 2021-02-25 | -$84.90M derived: sum of 3 quarters · filed 2021-02-25 | -$94.70M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$28.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$52.59M derived: sum of 2 quarters · filed 2019-11-05 | -$62.40M 10-Q · filed 2019-11-05 | -$64.54M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$24.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$34.24M 10-Q · filed 2019-07-31 | -$36.38M derived: sum of 3 quarters · filed 2020-02-25 | -$42.66M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$9.80M 10-Q · filed 2019-05-01 | -$11.95M derived: sum of 2 quarters · filed 2020-02-25 | -$18.22M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$8.42M derived: sum of 2 quarters · filed 2020-02-25 | -$32.84M 10-K · filed 2020-02-25 | |
| 2017-09-30 | -$6.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$30.70M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$24.42M 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | -$71.81M 10-K · filed 2019-02-27 | |||
| 2013-12-31 | -$33.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$77.92M derived: sum of 2 quarters · filed 2014-02-27 | -$130.70M derived: sum of 3 quarters · filed 2014-02-27 | -$190.34M 10-K · filed 2014-02-27 |
| 2013-09-30 | -$44.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$97.62M derived: sum of 2 quarters · filed 2013-11-07 | -$157.25M 10-Q · filed 2013-11-07 | -$201.02M derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-06-30 | -$52.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$112.42M 10-Q · filed 2013-08-08 | -$156.18M derived: sum of 3 quarters · filed 2014-02-27 | -$195.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-03-31 | -$59.63M 10-Q · filed 2013-05-09 | -$103.40M derived: sum of 2 quarters · filed 2014-02-27 | -$142.82M derived: sum of 3 quarters · filed 2014-02-27 | -$164.20M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-12-31 | -$43.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$83.18M derived: sum of 2 quarters · filed 2014-02-27 | -$104.57M derived: sum of 3 quarters · filed 2014-02-27 | -$122.30M 10-K · filed 2014-02-27 |
| 2012-09-30 | -$39.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$60.80M derived: sum of 2 quarters · filed 2013-11-07 | -$78.54M 10-Q · filed 2013-11-07 | -$90.11M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$21.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$39.12M 10-Q · filed 2013-08-08 | -$50.70M derived: sum of 3 quarters · filed 2014-02-27 | -$58.98M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$17.74M 10-Q · filed 2013-05-09 | -$29.31M derived: sum of 2 quarters · filed 2014-02-27 | -$37.59M derived: sum of 3 quarters · filed 2014-02-27 | -$48.37M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$19.85M derived: sum of 2 quarters · filed 2014-02-27 | -$30.63M derived: sum of 3 quarters · filed 2014-02-27 | -$39.44M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$8.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$19.05M derived: sum of 2 quarters · filed 2012-11-08 | -$27.86M 10-Q · filed 2012-11-08 | -$37.40M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$10.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$19.59M 10-Q · filed 2012-08-08 | -$29.12M derived: sum of 3 quarters · filed 2013-02-28 | -$37.48M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$8.81M 10-Q · filed 2012-05-08 | -$18.34M derived: sum of 2 quarters · filed 2013-02-28 | -$26.70M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | -$9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$17.89M derived: sum of 2 quarters · filed 2013-02-28 | -$33.87M 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$8.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$24.34M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$15.98M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$28.41M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |